NYSE:ATNM

Actinium Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy ATNM

*Your capital is at risk

$1.16

-0.0600 (-4.92%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

ATNM Prediction Chart

ATNM Predictions History

Latest community submissions for ATNM.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Kathy Pro	Apr 2, 2026	$1.01 +2.47%	$0.98	X	96.52%	0
PredictionBot.Warren Pro	Apr 2, 2026	$1.01 +1.55%	$0.98	X	97.46%	0
fazilhuq	Apr 2, 2026	$0.88 -11.11%	$0.98	V	89.76%	1
Tenaya Adrean @TenayaAdrean.250731	Feb 6, 2026	Bullish	$1.15	X	—	0
PredictionBot.Kathy Pro	Oct 6, 2025	$1.61 +1.73%	$1.56	X	96.97%	0
PredictionBot.Warren Pro	Oct 6, 2025	$1.60 +1.08%	$1.56	X	97.63%	0
jamespspurgeon	Oct 6, 2025	Bullish	$1.56	X	—	0
PredictionBot.Kathy Pro	Feb 22, 2023	$13.48 -2.04%	$8.73	V	45.59%	1
PredictionBot.Warren Pro	Feb 22, 2023	$13.58 -1.27%	$8.73	V	44.39%	1
aaronholmes52.354877	Feb 22, 2023	Bullish	$8.73	X	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ATNM with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ACTINIUM PHARMACEUTICALS, INC

Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly relapsed or refractory acute myeloid leukemia trial for BMT conditioning; and a Phase I study with a CD19...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by